Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sedentary Behavior 1Pain 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Insulin Resistance 1Hyperlipidemias 1Hyperglycemia 1Hematologic Neoplasms 1Delirium 1Advanced Cancer 1

Interventions

Standard of Care 9Exercise 9Educational Status 8Practice Guidelines as Topic 7Methods 7Blood Specimen Collection 7Early Intervention, Educational 6Palliative Care 5Interviews as Topic 5Behavior Therapy 5fludarabine 4Surveys and Questionnaires 4Physical Therapy Modalities 4Cyclophosphamide 4Magnetic Resonance Spectroscopy 3Health Promotion 3Granulocyte Colony-Stimulating Factor 3pegylated granulocyte colony-stimulating factor 2fludarabine phosphate 2Whole-Body Irradiation 2Therapeutic Touch 2Stem Cell Transplantation 2Restraint, Physical 2Radiosurgery 2Patient Navigation 2Parenteral Nutrition 2Low-Level Light Therapy 2Etoposide 2Cytarabine 2Control Groups 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Neoplasms × Olanzapine × Clear all
NCT00737191 2012-03-09

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Mayo Clinic

Phase NA Withdrawn
Other hematologic neoplasm

Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡